Variant report
Variant | nsv435775 |
---|---|
Chromosome Location | chr4:22026385-22032731 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571826366 | chr4:22028611-22028612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs376776442 | chr4:22028618-22028619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs539355222 | chr4:22028652-22028653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2015779 | chr4:22028672-22028673 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs368829635 | chr4:22028687-22028688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs367617352 | chr4:22028703-22028704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554233287 | chr4:22028705-22028706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149977129 | chr4:22028715-22028716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs111478659 | chr4:22028739-22028740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577740113 | chr4:22028777-22028778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541986456 | chr4:22028797-22028798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539822052 | chr4:22028827-22028828 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564927454 | chr4:22028920-22028921 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4696999 | chr4:22028976-22028977 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs547274923 | chr4:22031022-22031023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529998040 | chr4:22031076-22031077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542906577 | chr4:22031081-22031082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141165914 | chr4:22031085-22031086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150711532 | chr4:22031093-22031094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs137991603 | chr4:22031114-22031115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552722213 | chr4:22031134-22031135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374315338 | chr4:22031160-22031161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs75114055 | chr4:22031181-22031182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531964892 | chr4:22031207-22031208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4697262 | chr4:22031239-22031240 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs568200780 | chr4:22031279-22031280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs183762348 | chr4:22031284-22031285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34048835 | chr4:22031288-22031289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs372475674 | chr4:22031362-22031363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373171763 | chr4:22031437-22031438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs189276153 | chr4:22031438-22031439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149473642 | chr4:22031457-22031458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557649348 | chr4:22031483-22031484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147165437 | chr4:22031492-22031493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541125317 | chr4:22031500-22031501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543221833 | chr4:22031504-22031505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs140547993 | chr4:22031530-22031531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561284101 | chr4:22031586-22031587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574884358 | chr4:22031614-22031615 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs116175045 | chr4:22031642-22031643 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539640380 | chr4:22031696-22031697 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs10004742 | chr4:22031734-22031735 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527700623 | chr4:22031811-22031812 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546492850 | chr4:22031818-22031819 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs564773220 | chr4:22031836-22031837 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs115939392 | chr4:22031838-22031839 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs181233897 | chr4:22031842-22031843 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550035424 | chr4:22031857-22031858 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568139376 | chr4:22031911-22031912 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186210191 | chr4:22031925-22031926 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Breast cancer | 17133270 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Cancer | 22183965 | CNVD |
Gastric cancer | 16891809 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:22028600-22028800 | Enhancers | H9 Cell Line | embryonic stem cell |
2 | chr4:22028800-22029000 | ZNF genes & repeats | H9 Cell Line | embryonic stem cell |
3 | chr4:22031000-22032000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr4:22031000-22032200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr4:22031200-22032400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr4:22031600-22031800 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
7 | chr4:22031600-22032000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr4:22031600-22032200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr4:22031800-22032000 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
10 | chr4:22031800-22032200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |